Holt K H, Campbell K P
Howard Hughes Medical Institute, Department of Physiology and Biophysics, and Department of Neurology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
J Biol Chem. 1998 Dec 25;273(52):34667-70. doi: 10.1074/jbc.273.52.34667.
Four unique transmembrane glycoproteins comprise the sarcoglycan complex in striated muscle. The sarcoglycan complex contributes to maintenance of sarcolemma integrity. A shared feature of four types of autosomal recessive limb girdle muscular dystrophy (LGMD) is that mutations in a single sarcoglycan gene result in the loss of all sarcoglycans at the sarcolemma. The mechanism of destabilization is unknown. We report here our findings of sarcoglycan complex biosynthesis in a heterologous cell system. We demonstrate that the sarcoglycans are glycosylated and assemble into a complex that resides in the plasma membrane. Complex assembly was dependent on the simultaneous synthesis of all four sarcoglycans. Mutant sarcoglycans block complex formation and insertion of the sarcoglycans into the plasma membrane. This constitutes the first biochemical evidence to support the idea that the molecular defect in sarcoglycan-deficient LGMD is because of aberrant sarcoglycan complex assembly and trafficking, which leads to the absence of the complex from the sarcolemma.
四种独特的跨膜糖蛋白构成了横纹肌中的肌聚糖复合体。肌聚糖复合体有助于维持肌膜的完整性。四种常染色体隐性肢带型肌营养不良症(LGMD)的一个共同特征是,单个肌聚糖基因突变会导致肌膜上所有肌聚糖缺失。其不稳定机制尚不清楚。我们在此报告在异源细胞系统中肌聚糖复合体生物合成的研究结果。我们证明,肌聚糖会发生糖基化并组装成一个位于质膜的复合体。复合体的组装依赖于所有四种肌聚糖的同时合成。突变的肌聚糖会阻碍复合体的形成以及肌聚糖插入质膜。这构成了首个生化证据,支持了肌聚糖缺陷型LGMD的分子缺陷是由于异常的肌聚糖复合体组装和运输,从而导致肌膜上缺乏该复合体这一观点。